title: Development and application of a sensitive high performance ion-exchange chromatography method for the simultaneous measurement of dopamine, 5-hydroxytryptamine and norepinephrine in microdialysates from the rat brain.
abstract: A high performance liquid chromatography (HPLC) method based on cation exchange separation has been developed for the measurement of dopamine (DA), 5-hydroxytryptamine (5-HT) and norepinephrine (NE) in microdialysates. The separation conditions have been optimised for using electrochemical detection. All three bioamines were resolved in less than 22 min using isocratic conditions. The optimum oxidation potential for the three bioamines was found to be +0.4 V vs. in situ Ag/AgCl reference electrode. Linear regression analysis of HPLC-peak area as a function of concentrations in the range 1-50 ng x ml(-1) gave coefficients of correlation between 0.998 and 0.999. The limit of detection for DA, 5-HT and NE was found to be between 50 and 100 pg x ml(-1) with a signal to noise ratio of 3:1. The method has been applied to the simultaneous measurement of the three monoamines in microdialysates from the medial prefrontal cortex under basal conditions and following the administration of the antipsychotic drug clozapine (10 mg x kg(-1) s.c.).
authors.affiliation: In Vivo Neurochemistry, New Frontiers Science Park, Third Avenue, Essex CM19 5AW, Harlow, UK.
authors.forename: C A
authors.initials: CA
authors.lastname: Heidbreder
authors.forename: L
authors.initials: L
authors.lastname: Lacroix
authors.forename: A R
authors.initials: AR
authors.lastname: Atkins
authors.forename: A J
authors.initials: AJ
authors.lastname: Organ
authors.forename: S
authors.initials: S
authors.lastname: Murray
authors.forename: A
authors.initials: A
authors.lastname: West
authors.forename: A J
authors.initials: AJ
authors.lastname: Shah
mesh_terms: D000818:Animals; D014150:Antipsychotic Agents / Q000494:pharmacology; D001921:Brain / Q000187:drug effects / Q000378:metabolism*; D002852:Chromatography, Ion Exchange / Q000295:instrumentation / Q000379:methods*; D003024:Clozapine / Q000494:pharmacology; D004298:Dopamine / Q000378:metabolism*; D005110:Extracellular Space / Q000378:metabolism*; D016014:Linear Models; D008297:Male; D017551:Microdialysis / Q000295:instrumentation / Q000379:methods; D009474:Neurons / Q000187:drug effects / Q000378:metabolism*; D009638:Norepinephrine / Q000378:metabolism*; D017397:Prefrontal Cortex / Q000187:drug effects / Q000378:metabolism; D051381:Rats; D017207:Rats, Sprague-Dawley; D012559:Schizophrenia / Q000188:drug therapy / Q000378:metabolism / Q000503:physiopathology; D012701:Serotonin / Q000378:metabolism*
chemical_list: D014150:Antipsychotic Agents; D012701:Serotonin; D003024:Clozapine; D004298:Dopamine; D009638:Norepinephrine